Graves Disease study: BHV-1300
Official title Study of BHV-1300 in Graves' Disease
ClinicalTrials.gov ID: NCT06980649
What this study is testing
What is BHV-1300?
BHV-1300 is an investigational once‑daily subcutaneous injectable medicine being studied for Graves' Disease.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether BHV-1300 is safe for people with Graves' disease and how it changes disease markers.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- 1\. Participants must have serologically confirmed Graves' Disease.
You likely can't join if
- History of hyperthyroidism not caused by Graves' Disease (e.g., toxic adenoma or toxic multinodular goiter) and/or history of thyroid storm within...
- History of treatment with radioactive iodine or thyroid surgery.
The study team makes the final eligibility decision.
Where it is enrolling
- South Gate, California, United States
- Miami, Florida, United States
- Columbus, Georgia, United States
- Greenville, North Carolina, United States
- Canton, Ohio, United States
- Memphis, Tennessee, United States
- Dallas, Texas, United States
- Houston, Texas, United States
- Shavano Park, Texas, United States
- Fitzroy, Australia
- Herston, Australia
- Kotara, Australia
- Melbourne, Australia
- Oaklands Park, Australia
- Parkville, Australia
- St Leonards, Australia
- Torquay, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at South Gate, California, United States; Miami, Florida, United States; Columbus, Georgia, United States; Greenville, North Carolina, United States; Canton, Ohio, United States; Memphis, Tennessee, United States and 11 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.